๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Seoul
Clinical trial register · South Korea

Clinical Trials in Seoul, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 3364 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:49 UTC
3364
Studies in scope
all four open statuses
1829
Recruiting now
open to new participants
503
Lead sponsors
across recruiting studies
Top sites
Seoul 2820 Daegu 550 Seongnam-si 485 Busan 464 Goyang-si 395
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca195 Seoul National University Hospital187 Yonsei University147 Samsung Medical Center142 Merck Sharp & Dohme LLC112
Site location
Seoul2820 Daegu550 Seongnam-si485 Busan464 Goyang-si395
All 252 locations
Target enrolment
to

Trials with a site in Seoul

2820 of 3364 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
NCT06841354Triple Negative Breast Neoplasms
DrugsSacituzumab tirumotecan·Nab-paclitaxel·Gemcitabine·Paclitaxel
Merck Sharp & Dohme LLC
Phase 3
1,000
Goyang-si, Seongnam, Daegu, Seoul
2025-03-16
Active, closed
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
NCT06795048Neovascular Age-related Macular Degeneration (nAMD)
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Phase 4
274
Busan, Daegu, Seongnam-si, Seoul
2025-03-14
Recruiting
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
NCT06677060Heart Failure
AstraZeneca
Phase 3
11,300
Bucheon-si, Cheongju-si, Daegu, Seongnam-si, Seoul, Suwon, Wลnju, Yangsan
2025-03-14
Active, closed
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
NCT06764485Metastatic Castration-resistant Prostate Cancer
DrugsAbiraterone·Enzalutamide·Docetaxel
Celgene
Phase 3
960
Goyang-si, Seongnam, Seoul
2025-03-13
Recruiting
IVUS-Guided vs Angiography-Guided PCI in Acute Coronary Syndrome
NCT07512778Acute Coronary Syndromes (ACS)
SUK MIN SEO
Not applicable
1,500
Seoul
2025-03-13
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
NCT06785818B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals
Observational
500
Bundang Gu, Seongnam-si, Gyeonggi-do, Incheon, Seoul, Busan, Jeollanam, Ulsan
2025-03-12
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
NCT06615479Relapsed or Refractory Multiple Myeloma (RRMM)
DrugsBMS-986393·Carfilzomib·Pomalidomide·Daratumumab
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Seoul
2025-03-12
Recruiting
Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study
NCT06897176Stroke
Yonsei University
Phase 4
40
Seoul
2025-03-12
Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
NCT06792695Metastatic Colorectal Cancer
DrugsFOLFIRI (Fluorouracil (5-FU), leucovorin, irinotecan)·Volrustomig·Bevacizumab
AstraZeneca
Phase 2
80
Seoul, Yongin-si
2025-03-12
Recruiting
Validation of the Efficacy of Air Purifiers in Indoor Environment and Allergic Symptoms in Allergic Rhinitis Patients
NCT06890572Rhinitis Allergic
Yonsei University
Not applicable
44
Seoul
2025-03-11
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
NCT06641466Menstrual Migraine
DrugRimegepant
Pfizer
Phase 3
723
Hwaseong-si, Gangseo-gu, Seoul
2025-03-11
Recruiting
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
NCT06687941Neoplasms, Carcinoma, Hepatocellular, Carcinoma, Non-Small-Cell Lung, Liver Neoplasms
DrugAST-201
Aptamer Sciences, Inc.
Phase 1
70
Goyang-si, Seongnam, Seoul
2025-03-11
Recruiting
AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors
NCT06911333Solid Tumor, Adult, Tumor, Solid, Solid Tumor, Solid Tumor, Unspecified, Adult
Avelos Therapeutics Inc.
Phase 1/2
36
Seongnam-si, Seoul
2025-03-11
Recruiting
Building Evidence for Ablative Internal Radiation Therapy in Localized HCC Beyond the Up-To-7 Criteria
NCT06773845Hepatocellular Carcinoma (HCC), Radioembolization
Seoul National University Hospital
Phase 2
100
Gangneung, Anyang-si, Ilsan, Seongnam-si, Seoul
2025-03-11
Recruiting
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
NCT07246668Hepatocellular Carcinoma, Liver Neoplasms, Carcinoma, Hepatocellular
Yonsei University
Phase 2
52
Seoul
2025-03-10
Recruiting
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
NCT06884098Primary Hypercholesterolaemia
Addpharma Inc.
Phase 1
60
Seoul
2025-03-10
By invitation
The Efficacy of Aldehyde Dehydrogenase Enzyme in Essential Tremor Patients: A Single-Center Study
NCT07238725Essential Tremor
Pico Entech Co., Ltd.
Not applicable
40
Seoul
2025-03-10
Active, closed
Comparison of Safety and Efficacy Between the Robot-assisted System AVIAR (MX-02) Procedure and Conventional Manual Procedure in Patients Requiring Percutaneous Coronary Intervention
NCT06735716Percutaneous Coronary Intervention
Asan Medical Center
Observational
80
Seoul
2025-03-10
Active, closed
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
NCT06744647Antibody-Mediated Rejection, Kidney Transplantation, Biopsy-proven Histologic Scores, AMR
DrugALXN2030
Alexion Pharmaceuticals, Inc.
Phase 2
47
Seoul
2025-03-07
Recruiting
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
NCT06699771Lymphoma, T-Cell
DrugsFludarabine·Cyclophosphamide
GC Cell Corporation
Phase 1
53
Seoul
2025-03-07
Active, closed
An Ophthalmic Safety Study in Patients With Breast Cancer
NCT06767462Ophthalmic Safety in Patients With Breast Cancer
AstraZeneca
Observational
160
Seoul
2025-03-05
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
NCT06742996Mantle Cell Lymphoma, B Cell Lymphoma
DrugsSonrotoclax·Zanubrutinib
BeOne Medicines
Phase 3
300
Seogu, Seongnam-si, GangnamGu, SeochoGu, SeodaemunGu, Seoul, SongpaGu, Yeongdeungpo-gu
2025-03-05
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
NCT06806033Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma
DrugsGlofitamab·Obinutuzumab·Oxaliplatin·Gemcitabine
Hoffmann-La Roche
Phase 2
130
Seongnam-si, Seoul
2025-03-05
Recruiting
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
NCT06796907Tumours, Gynecological
DrugsMo-Rez·Dostarlimab·Bevacizumab
GlaxoSmithKline
Phase 1/2
305
Seoul
2025-03-04
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
NCT06742723Chronic Kidney Disease and Hypertension
DrugBaxdrostat/dapagliflozin
AstraZeneca
Phase 3
5,000
Ansan-si, Anyang-si, Busan, Cheonan-si, Goyang-si, Gwangju, Seongnam-si, Seoul
2025-03-03
Recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
NCT06671483Psoriatic Arthritis
DrugZasocitinib
Takeda
Phase 3
1,088
Suwon, Seoul
2025-03-03
Recruiting
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
NCT06841055Non-small Cell Lung Cancer
DrugsPumitamig·Docetaxel
BioNTech SE
Phase 2
60
Jinju, Cheongju-si, Incheon, Seoul
2025-03-03
Not yet open
Effects of Short Foot Exercise on Knee Pain, Muscle Tone, Balance, and Quality of Life in Flexible Flatfoot Patients
NCT06861322Flexible Flatfoot, Knee Pain, Balance Impairment, Quality of Life (QOL)
Sahmyook University
Not applicable
44
Seoul
2025-03-02
Not yet open
Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
NCT06843421Metabolic Dysfunction-Associated Steatotic Liver Disease, Cardiovascular Diseases
Korea University
Observational
6,000
Gyeonggi-do, Yongin, Seoul, Gangwon-do, Suwon
2025-03-01
Not yet open
The Incidence of New-brain Lesions on Brain MRI and Safety Between Edoxaban and Apixaban in Patients with Stroke and Nonvalvular Atrial Fibrillation
NCT06864052Stroke, Atrial Fibrillation
Ewha Womans University Seoul Hospital
Not applicable
400
Seoul
2025-03-01
Recruiting
A Phase โ…ข Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
NCT06764875HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
DrugsRilvegostomig·Trastuzumab deruxtecan·Trastuzumab·Adrucil
AstraZeneca
Phase 3
840
Daegu, Goyang-si, Gyeonggi-do, Jeonnam, Seoul
2025-03-01
Not yet open
Safety & Efficacy of a Novel Asymmetrical Linear Stapler (NALS) for Securing Distal Resection Margin in Laparoscopic Rectal Cancer Surgery: Pilot Study
NCT06709170Colo-rectal Cancer
Seoul National University Hospital
Not applicable
60
Seoul
2025-03-01
Not yet open
Application-Delivered Patient Education in Enhancing the Usage of Apixaban in Patients With Atrial Fibrillation
NCT06869083Atrial Fibrillation on Apixaban Treatment
Yonsei University
Not applicable
5,200
Seoul
2025-03
Recruiting
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
NCT06855498Hidradenitis Suppurativa (HS)
DrugPovorcitinib
Incyte Corporation
Phase 3
600
Ansan-si, Busan, Incheon, Seoul, Yangsan
2025-02-28
Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
NCT06780137Small Cell Lung Cancer
DrugsGocatamig·Ifinatamab Deruxtecan·Durvalumab
Merck Sharp & Dohme LLC
Phase 1/2
327
Seoul
2025-02-27
By invitation
Digital Phenotypes for Predicting Depression
NCT07151846Depression - Major Depressive Disorder, Depression Bipolar, Bipolar Disorder (BD), Mood Disorders
Korea University Anam Hospital
Observational
540
Seoul
2025-02-27
Recruiting
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
NCT06780670Prostate Cancer
DrugAAA817
Novartis Pharmaceuticals
Phase 2/3
443
Seoul
2025-02-27
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
NCT06722235Immune Thrombocytopenic Purpura (ITP)
DrugMezagitamab
Takeda
Phase 3
171
Seongnam-si, Daegu, Seoul
2025-02-27
Active, closed
A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC
NCT06745323Small Cell Lung Cancer (SCLC)
DrugTarlatamab
Amgen
Phase 2
252
Cheongju Chungbuk, Daegu, Hwasun-gun, Jeollanam-do, Seongnam-si, Gyeonggi-do, Seoul
2025-02-26
Recruiting
South Korean Study to Prevent Frailty and Aging-related Diseases Through Lifestyle Intervention
NCT06891573Frailty
Seong Hye Choi, MD
Not applicable
40
Incheon, Seoul, Suwon
2025-02-26
Recruiting
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
NCT06686394Breast Neoplasms, Breast Cancer
DrugsOgivri·Herzuma·Patritumab deruxtecan·Tucatinib
Merck Sharp & Dohme LLC
Phase 1/2
81
Seoul
2025-02-26
Recruiting
Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea
NCT06928818Cancer of Breast, Trastuzumab Emtansine, Trastuzumab Deruxtecan
Seoul National University Hospital
Observational
100
Seoul
2025-02-26
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjรถgren's Syndrome (SS)
NCT06747949Sjรถgren's Syndrome
DrugDazodalibep
Amgen
Phase 3
844
Seoul
2025-02-25
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
NCT06646276Extensive-Stage Small Cell Lung Cancer
DrugsEtoposide·Atezolizumab·Nivolumab·Carboplatin
Bristol-Myers Squibb
Phase 3
530
Cheongju-si, Seongnam, Suwon, Seoul, Daegu
2025-02-25
Recruiting
Efficacy and Safety of HANAROSTENยฎ HOT Plumberโ„ข With Z-EUSITโ„ข for Pancreatic Pseudocyst Drainage
NCT06855485Pancreatic Pseudocyst
Asan Medical Center
Not applicable
20
Seoul
2025-02-25
Recruiting
LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea
NCT06946784Tuberculosis, Post Tuberculosis
Yonsei University
Observational
360
Seoul
2025-02-25
Recruiting
Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)
NCT06889818Mild Cognitive Impairment, Dementia, Subjective Cognitive Decline (SCD), Alzheimer Disease
Ewha Womans University Mokdong Hospital
Observational
4,000
Incheon, Seoul
2025-02-24
Recruiting
A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1
NCT06867497Metastatic Adenocarcinoma of the Pancreas
Boryung Pharmaceutical Co., Ltd
Phase 1
20
Seoul
2025-02-24
Recruiting
Effect of Cervical Lymphaticovenous and Lymph Node-to-Vein Anastomosis in Patients With Intracranial Lymphatic Circulation Disorder
NCT07328386Intracranial Lymphatic Circulation Disorder, Alzheimer's Disease
Hong Joonpio
Not applicable
114
Seoul
2025-02-20
Recruiting
UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies
NCT06590961Relapsed/Refractory B-cell Malignancies
Ubix Therapeutics, Inc.
Phase 1
94
Seoul
2025-02-20
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819Advanced Solid Tumors, HER2 Mutation
DrugSevabertinib
Bayer
Phase 2
111
Jongno -Gu, Seoul
2025-02-13
Active, closed
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
NCT06834347Chronic Rhinosinusitis With Nasal Polyps
DrugsItepekimab·Mometasone furoate
Sanofi
Phase 3
231
Cheonan-Si, Seongnam-si, Incheon, Seoul
2025-02-12
Recruiting
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
NCT06770933Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy
Vantage Biosciences Ltd
Phase 2
100
Seongnam-si, Seoul
2025-02-11
Recruiting
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
NCT06858579Chronic Inflammatory Demyelinating Polyneuropathy
DrugClaseprubart
Dianthus Therapeutics
Phase 3
256
Daegu, Daejeon, Seoul, Uijeongbu-si, Yangsan
2025-02-10
Active, closed
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293Menstrual Migraine (MM)
DrugAtogepant
AbbVie
Phase 3
468
Hwaseong, Seoul
2025-02-10
Active, closed
Lipoprotein(a) and Progression of Aortic Stenosis
NCT06648915Aortic Valve Stenosis, Lipoprotein(a)
Asan Medical Center
Observational
364
Seoul
2025-02-10
Recruiting
Skin-to-skin Contact in Healthy Term Infants
NCT06777524Skin-to-skin Contact
Korea University Anam Hospital
Not applicable
130
Seoul
2025-02-10
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920Generalized Myasthenia Gravis
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
180
Seoul, Busan
2025-02-07
Recruiting
Branched Chain Amino Acids for Sarcopenia in Patients Undergoing Total Knee Arthroplasty
NCT07634523Sarcopenia, Total Knee Arthroplasty
Seoul National University Hospital
Phase 4
140
Seongnam-si, Seoul
2025-02-06
Recruiting
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
NCT06712355Extensive-stage Small-cell Lung Cancer
DrugsPumitamig·Etoposide·Atezolizumab·Carboplatin
BioNTech SE
Phase 3
621
Seoul, Goyang-si, Suwon, Jinju, Incheon, Cheongju-si
2025-02-03
Recruiting
Smartwatch-Based AI Model for OSA Prediction (SWOSA)
NCT06792188Obstructive Sleep Apnea of Adult, Screening, Smart Watch
Seoul National University Hospital
Observational
147
Seoul
2025-02-03
Recruiting
Conventional Versus Hypofractionated Radiotherapy With Temozolomide in Elderly Glioblastoma
NCT05439278Glioblastoma
DrugTemozolomide
Severance Hospital
Phase 3
178
Seoul
2025-02-01
Recruiting
Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal Gastrectomy
NCT06841484Gastric Cancer
Gangnam Severance Hospital
Not applicable
36
Seoul
2025-02-01
Recruiting
Comparison of Ropivacaine-Poloxamer 407 Hydrogel and TAP Block for Postoperative Pain Management in Laparoscopic/Robotic Gastrectomy
NCT06839716Gastric Cancer
Gangnam Severance Hospital
Not applicable
134
Seoul
2025-02-01
By invitation
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
NCT06679881Hereditary Angioedema (HAE)
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 3
170
Daegu, Seoul
2025-02-01
Not yet open
Transanal Irrigation for Low Anterior Resection Syndrome
NCT06796296Low Anterior Resection Syndrome, Rectal Cancer Surgery, Insomnia
Seoul National University Hospital
Not applicable
94
Seoul
2025-02-01
Recruiting
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
NCT06888388Breast Cancer Surgery
Sir Mortimer B. Davis - Jewish General Hospital
Observational
4,700
Seoul
2025-02-01
Not yet open
CompARing Between CO2 Phenylephrine and Phenylephrine Only Treatment in Patients With proGrEssing Cerebral infarctioN
NCT06770426Acute Ischemic Stroke
DrugPhenylephrine
Yonsei University
Phase 3
40
Seoul
2025-02
By invitation
Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia
NCT07163260Haemophilia
Novo Nordisk A/S
Observational
244
Seoul
2025-01-31
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Busan, Seoul
2025-01-30
Recruiting
Ropivacaine-Poloxamer 407 Gel for Pain Control After Open Gastrectomy
NCT06778954Gastric Cancer
Gangnam Severance Hospital
Not applicable
48
Seoul
2025-01-30
Recruiting
Venetoclax and Decitabine in R/R T-ALL
NCT06712121T Lymphoblastic Leukemia/Lymphoma
DrugsDecitabine·Venetoclax
Seoul National University Hospital
Phase 2
28
Seongnam-si, Seoul
2025-01-30
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Hwasun-gun, Busan, Daegu, Seongnam, Seoul
2025-01-29
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Busan, Goyang-si, Hwasun, Seongnam, Seoul
2025-01-28
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
NCT06717347Diffuse Large B-Cell Lymphoma
DrugsRituximab Biosimilar·Zilovertamab vedotin·Prednisolone·Methylprednisolone
Merck Sharp & Dohme LLC
Phase 3
1,046
Goyang-si, Busan, Daejeon, Seoul
2025-01-27
Recruiting
SB17170 Phase 2 Trial in IPF Patients
NCT06747923IPF, Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
DrugSB17170
SPARK Biopharma
Phase 2
30
Goyang, Gwangmyeong, Seoul, Suwon
2025-01-27
Recruiting
Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation
NCT06699342Atrial Fibrillation (AF)
Seoul National University Hospital
Not applicable
50
Seoul
2025-01-27
Recruiting
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
NCT06100289Ulcerative Colitis, Crohn's Disease
DrugVedolizumab
Takeda
Phase 3
70
Daegu, Seoul
2025-01-22
Recruiting
Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
NCT06630130Stomach Neoplasms
DrugsSonesitatug Vedotin·Rilvegostomig·Xeloda·Trastuzumab deruxtecan
Jeeyun Lee
Phase 2
100
Seoul
2025-01-22
Active, closed
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
NCT06632951Urothelial Carcinoma
DrugsLivmoniplimab·Budigalimab·Docetaxel·Gemcitabine
AbbVie
Phase 2
150
Goyang-si, Hwasun-gun, Seoul
2025-01-20
Recruiting
Clinical Impact of Non-invasive Neurally Adjusted Ventilatory Assist in Very Preterm Infants
NCT06786039Preterm Infant
Korea University Anam Hospital
Observational
80
Seongnam-si, Seoul
2025-01-20
Recruiting
Effects of Enavogliflozin on Coronary Microvascular and Cardiac Function in Obesity
NCT06782139Obesity and Type 2 Diabetes
DrugEnavogliflozin
Korea University Anam Hospital
Phase 4
30
Seoul
2025-01-20
Recruiting
Effects of Allogenic Umbilical Cord-Derived Mesenchymal Stem Cells on Patients With Rotator Cuff Disease
NCT06794294Rotator Cuff Disease
Seoul National University Hospital
Phase 1/2
21
Seoul
2025-01-17
Recruiting
Arthroscopic Rotator Cuff Repair with UC-MSCs for Large to Massive Tears
NCT06817616Rotator Cuff Disease
Korea University Anam Hospital
Not applicable
15
Seoul
2025-01-17
Recruiting
Intrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy
NCT06761989Pain Management, Pain, Postoperative
DrugMorphine
Seoul National University Hospital
Not applicable
104
Seoul
2025-01-15
Recruiting
Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity
NCT06756061GVHD - Graft-Versus-Host Disease, Neoplasms, Haematopoietic Stem Cell Transplantation
DrugsJakavi·Ruxolitinib·Prednisone
Byung-Sik Cho
Phase 2
88
Seoul
2025-01-15
By invitation
An Exploratory Preliminary Study on the Effect of Combined Transcranial Photobiomodulation(tPBM)-Transauricular Vagus Nerve Stimulation(taVNS) on Alcohol Craving and Neurophysiological Marker in Drinkers (in South Korea)
NCT07071493Normal Subjects
Yonsei University
Not applicable
60
Seoul
2025-01-15
Active, closed
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjรถgren's Syndrome
NCT06684847Primary Sjogrens Disease
DrugEfgartigimod PH20
argenx
Phase 3
631
Anyang-si, Suwon, Gwangju, Seoul
2025-01-15
Active, closed
Sexuality and Relationship Education Program for Autistic Young Adults in South Korea
NCT07234253Autism Spectrum Disorder
Korea University
Not applicable
30
Seoul
2025-01-14
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
NCT06695845Breast Cancer, Gastric Cancer, Esophageal Cancer, Gastroesophageal Cancer
DrugZanidatamab
Jazz Pharmaceuticals
Phase 2
200
Suwon, Hwasun-Eup, Gangnam-gu, Guro-gu, Jongno-gu, Seodaemun-gu, Seoul
2025-01-14
Recruiting
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
NCT06365840TMB-H, Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
DrugDanburstotug
ImmuneOncia Therapeutics Inc.
Phase 2
30
Goyang, Seongnam, Seoul
2025-01-13
Recruiting
Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients
NCT06421285Breast Neoplasms
Asan Medical Center
Not applicable
60
Seoul
2025-01-10
Recruiting
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
NCT06589596Advanced Solid Tumor
DrugBGB-58067
BeOne Medicines
Phase 1
525
PaldalGu SuwonSi, Seongnam-si, GangnamGu, SeodaemunGu, Seoul, SongpaGu
2025-01-10
Recruiting
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
NCT06706076NSCLC (Advanced Non-small Cell Lung Cancer)
BlossomHill Therapeutics
Phase 1/2
675
Seoul
2025-01-09
Recruiting
The Effect of Preoperative Albumin Administration on Postoperative Acute Kidney Injury in Pediatric Patients With Hypoalbuminemia Undergoing Cardiac Surgery
NCT06710353Acute Kidney Injury, Pediatric Cardiac Surgery
DrugsCrystalloid solutions·Albumin
Seoul National University Hospital
Not applicable
190
Seoul
2025-01-09
Recruiting
IRIS-Coroflex NEO Cohort
NCT06177743Coronary Artery Stenosis, Coronary Artery Disease
Seung-Jung Park
Observational
1,000
Seoul, Bucheon-si, Daegu, Gwangju, Ilsan, Sejong, Suwon, Uijeongbu-si
2025-01-09
By invitation
Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.
NCT06779071Knee Osteoarthritis
PharmaResearch Co.,Ltd
Phase 3
260
Seoul
2025-01-08
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Seogu, Gwangju, Anyang-si, Seongnam-si, Seoul
2025-01-08
Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
NCT06712316Non-small Cell Lung Cancer
DrugsPumitamig·Pemetrexed·Paclitaxel·Carboplatin
BioNTech SE
Phase 2/3
1,580
Cheongju-si, Daejeon, Goyang-si, Incheon, Jinju, Seongnam-si, Seoul, Suwon
2025-01-07
Active, closed
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
NCT06760637Breast Cancer
DrugsAtirmociclib·Ribociclib·Abemaciclib·Palbociclib
Pfizer
Phase 3
1,035
Seongnam-si, Incheon, Goyang-si, Seongnam, Gangnam-gu, Seoul
2025-01-06
Rows per page Showing 901–1000 of 2820
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 September 2026. https://priyalifescience.com/clinical-trials-south-korea/city/seoul?page=10

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,364 studies in total at the last sync on 26 Sep 2026, 19:49 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,820 of those studies with a site in Seoul.

How many clinical trials are recruiting in Seoul?

1,518 of the 2,820 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:49 UTC sync. A further 209 have not yet opened recruitment, 1,015 are active but closed to new participants, and 78 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.